Brady S. Laughlin, M.D.

Location

Contact

SUMMARY

Brady S. Laughlin, M.D., is a radiation oncologist whose research focuses on cancers of the urinary system and reproductive organs and childhood cancers, including Wilms tumor, neuroblastoma and Hodgkin lymphoma.

Focus areas

• Optimizing radiation therapy approaches in pediatric cancers. Dr. Laughlin investigates alternative radiation fractionation strategies and techniques to improve outcomes while minimizing toxicity in pediatric patients.
• Advanced radiation therapy techniques. Dr. Laughlin explores the role of proton therapy and emerging radiation modalities in the treatment of pediatric and genitourinary cancers. His goal is to enhance tumor control and reduce long-term side effects.

Significance to patient care

Dr. Laughlin's research is designed to improve clinical outcomes, reduce treatment-related harm and improve the radiation therapy experience for pediatric cancer patients, patients with cancers of the urinary system and reproductive organs, and their families.

Professional highlights

• Member, Children's Oncology Group, National Clinical Trials Network, National Cancer Institute, 2024-present.
• Co-principal investigator, Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients with Non-Metastatic Breast Cancer, Mayo Clinic, 2025-2034.
• Co-principal investigator, Risk Stratified De-escalated Hormone Therapy with Radiation Therapy for the Treatment of Prostate Cancer, Mayo Clinic, 2024-2027.